Cohance Lifesciences Names Abhimanyu Ojha as CFO
Cohance Lifesciences has appointed Abhimanyu Ojha as CFO, bringing leadership experience from Viatris, Mylan, Sun Pharma and Ranbaxy Laboratories.
Industrial talks | 12/10/2026 | By News Bureau
Eris Lifesciences Appoints Chirag Mehta as Executive Director
Eris Lifesciences has appointed Chirag Mehta as Executive Director to oversee finance, investor relations and international business.
Industrial talks | 07/10/2026 | By News Bureau
PRIP Approves INR 1,600 Crore for 41 Pharma and MedTech Projects
The PRIP first round has approved INR 1,600 crore for 41 pharma and medtech innovation projects, spanning novel drug discovery and advanced medical technologies.
Industrial talks | 01/10/2026 | By News Bureau
DoP Launches INR 50 Crore Funding Track for Startups and MSMEs
DoP has launched a new discovery track offering up to INR 50 crore under PRIP scheme for startups and MSMEs, with applications open for pharma and medtech innovation.
Industrial talks | 01/10/2026 | By News Bureau | 127
Morepen Labs Makes First US ANDA Submission
Morepen strengthens its CDMO capabilities with its first US ANDA submission, expanding formulation, bioequivalence and regulatory expertise for regulated markets.
Industrial talks | 30/09/2026 | By News Bureau
Nanomedicine to Advance Precision and Personalised Care, says Dr. Jitendra Singh
Dr. Jitendra Singh highlights nanomedicine’s role in precision healthcare as DBT supports 210 R&D projects with INR 174 crore to advance innovation.
Industrial talks | 29/09/2026 | By News Bureau
Goyal Calls for Global Partnerships to Drive India's Pharma Innovation
Commerce and Industry Minister Piyush Goyal has invited global pharmaceutical companies to deepen partnerships with India, focusing on innovation, advanced manufacturing, technology, clinical research and affordable healthcare.
Industrial talks | 24/09/2026 | By News Bureau
Crisil Projects 11-13 Percent Revenue Growth for Indian Pharma Sector
India’s pharmaceutical sector is projected to grow 11-13 percent in revenue this fiscal, supported by exports and domestic demand, according to Crisil Ratings.
Industrial talks | 24/09/2026 | By News Bureau
Hikal Shareholders Approve Sameer Hiremath as Chairman and MD
Hikal shareholders have approved Sameer Hiremath as Chairman and Managing Director for a five-year term starting October 1, 2026.
Industrial talks | 24/09/2026 | By News Bureau
European Pharma Leaders Warn of Declining Global Competitiveness
European pharmaceutical leaders have urged policymakers to strengthen investment in medicines and improve the region’s competitiveness in global pharma innovation.
Industrial talks | 23/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy